Human-Machine Collaboration to Redefine Healthcare Market in 2018
|
By HospiMedica International staff writers Posted on 26 Dec 2017 |

Image: The gap between AI and humans is expected to be bridged in 2018 through a collaboration of humans and machines (Photo courtesy of Techora).
Human-machine collaboration will bridge the gap between artificial intelligence (AI) and humans in 2018, leaving aside the man versus machine competition. Non-traditional players such as Amazon, Apple, Google, and IBM will start having a tangible impact on the healthcare ecosystem. Competing outside their conventional arena, these organizations are pushing traditional healthcare companies to break their main business model and make healthcare more accessible, affordable, and consumer-centric.
These were some of the expert insights offered at Frost & Sullivan’s (Santa Clara, CA, USA) Growth Innovation Leadership (GIL) briefing titled, "Global Healthcare Market Key Predictions for 2018" held on December 13, 2017. Frost & Sullivan's experts have predicted another year of big disruptions, transformations and innovations as the healthcare industry continues to overhaul outmoded business models. Advances in areas ranging from cancer immunotherapy products to blood testing, as well as the convergence of cutting-edge technology such as AI and blockchain, will help shape the healthcare industry into a much-anticipated, value-based care paradigm.
2018 is expected to be a tipping point for the mainstream adoption of popular digital health tech/solutions (AI, mHealth/wearables, telehealth, Big Data analytics, and robotics) and the transition of noble technologies from research/proof-of-concept to actionable healthcare and clinical applications (blockchain and cancer immunotherapy products). Additionally, cloud-based PaaS/SaaS platforms will become integral to any healthcare data monetization model, and the transition of these technologies from ideation to actionable applications will drive growth opportunities across the world.
Furthermore, data monetization will unleash the power of patient data to achieve better outcomes across the healthcare value chain. The digital transformation of patient monitoring, coupled with data hubs using cell phone networks, will drive health revenue, thereby further reducing hospital inpatient census. There will be increasing awareness about the current inefficiencies in healthcare delivery, such as poor utilization of operating theaters. There will be high demand for optimization of resources, care coordination employing technology-based platforms, and products or services that improve the efficiency of healthcare delivery. Highly capitalized players such as Amazon, Alibaba, and Google will reshape whole segments of healthcare, revolutionizing and simplifying patient experiences and patient empowerment.
"Algorithms have outperformed humans in many cases. In 2018, the work of AI will begin to see fruition particularly in the diagnostic imaging market. Therefore, clinicians will start embracing this technology and use it more freely and easily," said Reenita Das, Partner, and Senior Vice President of Transformational Health at Frost & Sullivan.
"Blockchain technology will move from perceived hype to reality bandwagon demonstrating real value with initial commercial deployments across health insurance claim adjudication and revenue cycle management use cases. The debate will now move onto the topic of adoption, exploring [how] and [where] can blockchain technology be used in the healthcare space," added Kamaljit Behera, Industry Analyst, Visionary Healthcare at Frost & Sullivan.
Related Links:
Frost & Sullivan
These were some of the expert insights offered at Frost & Sullivan’s (Santa Clara, CA, USA) Growth Innovation Leadership (GIL) briefing titled, "Global Healthcare Market Key Predictions for 2018" held on December 13, 2017. Frost & Sullivan's experts have predicted another year of big disruptions, transformations and innovations as the healthcare industry continues to overhaul outmoded business models. Advances in areas ranging from cancer immunotherapy products to blood testing, as well as the convergence of cutting-edge technology such as AI and blockchain, will help shape the healthcare industry into a much-anticipated, value-based care paradigm.
2018 is expected to be a tipping point for the mainstream adoption of popular digital health tech/solutions (AI, mHealth/wearables, telehealth, Big Data analytics, and robotics) and the transition of noble technologies from research/proof-of-concept to actionable healthcare and clinical applications (blockchain and cancer immunotherapy products). Additionally, cloud-based PaaS/SaaS platforms will become integral to any healthcare data monetization model, and the transition of these technologies from ideation to actionable applications will drive growth opportunities across the world.
Furthermore, data monetization will unleash the power of patient data to achieve better outcomes across the healthcare value chain. The digital transformation of patient monitoring, coupled with data hubs using cell phone networks, will drive health revenue, thereby further reducing hospital inpatient census. There will be increasing awareness about the current inefficiencies in healthcare delivery, such as poor utilization of operating theaters. There will be high demand for optimization of resources, care coordination employing technology-based platforms, and products or services that improve the efficiency of healthcare delivery. Highly capitalized players such as Amazon, Alibaba, and Google will reshape whole segments of healthcare, revolutionizing and simplifying patient experiences and patient empowerment.
"Algorithms have outperformed humans in many cases. In 2018, the work of AI will begin to see fruition particularly in the diagnostic imaging market. Therefore, clinicians will start embracing this technology and use it more freely and easily," said Reenita Das, Partner, and Senior Vice President of Transformational Health at Frost & Sullivan.
"Blockchain technology will move from perceived hype to reality bandwagon demonstrating real value with initial commercial deployments across health insurance claim adjudication and revenue cycle management use cases. The debate will now move onto the topic of adoption, exploring [how] and [where] can blockchain technology be used in the healthcare space," added Kamaljit Behera, Industry Analyst, Visionary Healthcare at Frost & Sullivan.
Related Links:
Frost & Sullivan
Latest Business News
- GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
- Medtronic and GE HealthCare Broaden Alliance Across Monitoring and Care Solutions
- Quantum Surgical Acquires NeuWave from Johnson & Johnson
- Medtronic to Acquire Coronary Artery Medtech Company CathWorks
- Medtronic and Mindray Expand Strategic Partnership to Ambulatory Surgery Centers in the U.S.
- FDA Clearance Expands Robotic Options for Minimally Invasive Heart Surgery
- WHX in Dubai (formerly Arab Health) to debut specialised Biotech & Life Sciences Zone as sector growth accelerates globally
- WHX in Dubai (formerly Arab Health) to bring together key UAE government entities during the groundbreaking 2026 edition
- Interoperability Push Fuels Surge in Healthcare IT Market
- Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies
- B. Braun Acquires Digital Microsurgery Company True Digital Surgery
- CMEF 2025 to Promote Holistic and High-Quality Development of Medical and Health Industry
- Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
- Medtronic Partners with Corsano to Expand Acute Care & Monitoring Portfolio in Europe
- Expanded Collaboration to Transform OR Technology Through AI and Automation
- Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more







